Navigation Links
Pharco Pharma NV/SA Leverages Advantages of Cloud Computing With the Implementation of Veeva CRM
Date:9/14/2011

BARCELONA, September 14, 2011 /PRNewswire/ --

Pharco Pharma NV/SA, a rapidly growing pharmaceutical company specialising in prescribed, OTC medications (OTX) and food supplements, has implemented Veeva CRM to support its salesforce in Belgium. Pharco required an affordable and intuitive Customer Relationship Management (CRM) application that was both pharma-specific and easily adaptable. The company turned to Veeva CRM, the leading cloud-based solution for the global pharma and biotech industry.

Pharco selected Veeva CRM after years of frustration with less than ideal solutions. In fact, in 2007, dissatisfied with the high cost, rigidity, and poor adoption of its existing automated CRM solution, the company made the bold move to abandon it and revert to "pen and paper." Always regarded as a temporary solution, the manual system could not provide management with visibility into the effectiveness of the salesforce, nor was it practical given the company's rapid growth.

"Knowing the perils of selecting the wrong partner, we were especially diligent in our search," noted Karel Goderis, managing director for Pharco. "We were looking for a cloud-based CRM solution, designed for pharma, that would be simple to use, cost effective, and flexible enough to grow along with our organisation. Veeva was the only solution that met our criteria in full."  

"Veeva CRM has already proven that it can sustain our annual growth rate of 40 percent, it has been nimble and fast to implement, and has spared us the expense of installing and managing onsite IT infrastructure," continued Goderis.

Veeva Systems has rapidly become the leading provider of Pharma CRM solutions globally. Cloud-based, Veeva CRM requires no hardware or software to purchase, scale or maintain. In addition, all Veeva customers benefit from free, automatic upgrades so users are always on the most up-to-date version of the software and benefit from the very latest compliance changes and system enhancements. Changes can be made to the system instantly without user retraining or additional third-party costs.

Goderis concluded, "Since our implementation of Veeva CRM, we've seen significant improvements including: increased field force efficiency, easier tracking of rep activity, and improved customer targeting."    

About Pharco Pharma NV/SA

Pharco is a publicly listed company (PHAR:BB) specialising in prescribed food supplements. Since 2001 Pharco has developed and marketed products in Belgium and a number of other European countries. For more information please visit via http://www.pharco.be.

About Veeva CRM

The Veeva CRM suite of applications, comprised of VBioPharma, iRep, VMobile, and VInsights, is the pharmaceutical and biotechnology industry's leading cloud-based CRM solution. In addition, iRep has quickly become the industry's choice for closed loop marketing on the iPad. Only Veeva CRM accommodates the unique needs of multiple commercial teams in a single solution, improving user adoption and sales effectiveness, while reducing cost and complexity. Veeva CRM is now the foundation on which the pharmaceutical industry is innovating its sales and marketing models for the future.

About Veeva Systems

Veeva Systems is the leader in cloud-based solutions for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has over 100 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Paris, Beijing, Shanghai, and Tokyo. For more information, visit http://www.veevasystems.com.

Copyright (c) 2011 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

Media Contact
Selma Nawaz
European Marketing Director
Veeva Systems
selma.nawaz@veevasystems.com
+34-93-1870200



'/>"/>
SOURCE Veeva Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kremers Urban Pharmaceuticals Inc. Settles Concerta® Patent Litigation
2. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
3. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
4. American Pharmacists Association Partners with HHS, CDC and CMS in the Million Hearts Initiative
5. Edison Pharmaceuticals, Inc. Closes Financing
6. Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
7. MD On-Line Acquires Strategic Edge Communications, Expands Provider Offerings to Include Pharmaceuticals
8. Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference
9. CPR+ Specialty Pharmacy Software Receives Surescripts Certification for e-Prescribing
10. IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
11. PDL BioPharma to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... LONDON , Feb.8, 2016 Cardiovascular ... Summary GlobalData,s Medical Devices sector report, ... 2015" provides an overview of Cardiovascular Surgery Devices ... --> The report provides comprehensive ... of the products at various stages of development. ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... , ... i2i Systems, an early innovator and developer of population health management ... KLAS report, Population Health Management 2015: How Far Can Your Vendor Take You? ... (PHM). The latest KLAS Report, leveraging over 200 user interviews, shines a light ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenntag Specialties, Inc.(BSI) ... Food & Beverage and Dietary Supplement market segments across ... and USA geographies east of the Rocky Mountains since 2012. Consistent performance ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering ... pouches, bags, and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, ... step up to semi-automatic or fully-automatic case packing with a small footprint, rugged, ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... serving the greater Venice, FL area, has initiated a fundraiser for a two ... accident just four days after Christmas. To support this beautiful child who is ...
(Date:2/8/2016)... ... , ... FileHold's document management software has been implemented by ... environment for FileHold software that is pay per user subscription-based and also does ... FileHold web services API. DocuSyst also advises clients on fully functioning back up ...
Breaking Medicine News(10 mins):